| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |